Houston-based University of Texas MD Anderson Cancer Center is collaborating with artificial intelligence company Exscientia to develop new oncology treatments.
Read the full post on Becker's Hospital Review - Healthcare News
MD Anderson, Exscientia collaborate on AI-powered drug development
